EPLIN ALS BIOMARKER FÜR KREBS

European patent · EP4133108 · In force

Register entry

Publication number
EP4133108
Application number
EP21723786
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Apr 9, 2021
Published
Feb 15, 2023
Granted
Apr 29, 2026
Protection ends at the latest
Apr 8, 2041
Next annual fee due
Apr 30, 2027
IPC classes
C12Q 1/6886 (2018.01)
Priority
FI 20205381 09.04.2020
PCT application
PCT/FI2021/050260 09.04.2021
PCT publication
WO2021/205078 14.10.2021
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. May 20, 2026

    Agent entered

    Representative
    Bovard AG, Optingenstrasse 16, 3013 Bern

    Published in Swissreg on 20.05.2026

  2. Apr 29, 2026

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 29.04.2026

Parties

Holder

THESTRA Oy

c/o Jukka Westermarck Tykistökatu 6A, Turku 20520, FI

Agent

Bovard AG

Optingenstrasse 16, 3013 Bern

Inventor

VENTELÄ, Sami

20014 Turun yliopisto, FI

WESTERMARCK, Jukka

20014 Turun yliopisto, FI

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.